Table 2.
Type | Cases |
CyclinD1 |
P |
E-cad |
P |
α-cat |
P |
β-cat |
P |
γ-cat |
P | |||||
Positive | Negative | Preserved | Reduced | Preserved | Reduced | Preserved | Reduced | Preserved | Reduced | |||||||
Histologicalgrade | ||||||||||||||||
I | 16 | 6 | 10 | 5 | 11 | 7 | 9 | 10 | 6 | 8 | 8 | |||||
II | 35 | 15 | 20 | > 0.05 | 5 | 30 | < 0.05 | 11 | 24 | > 0.05 | 24 | 11 | > 0.05 | 19 | 16 | < 0.05 |
III | 11 | 6 | 5 | 0 | 11 | 1 | 10 | 6 | 5 | 3 | 8 | |||||
Depth of invasion | ||||||||||||||||
T3 | 12 | 6 | 6 | > 0.05 | 4 | 8 | > 0.05 | 4 | 8 | > 0.05 | 6 | 6 | > 0.05 | 5 | 7 | > 0.05 |
T4 | 50 | 31 | 19 | 6 | 44 | 15 | 35 | 34 | 16 | 25 | 25 | |||||
Lymph node metastases | ||||||||||||||||
Positive | 35 | 14 | 21 | > 0.05 | 6 | 29 | > 0.05 | 9 | 26 | > 0.05 | 23 | 12 | > 0.05 | 12 | 23 | < 0.05 |
Negative | 27 | 13 | 14 | 4 | 23 | 10 | 17 | 17 | 10 | 18 | 9 |